An article on Healthcare Informatics caught our eye. It summarizes a recent presentation by Johns Hopkins CMIO Peter Greene and concludes as follows:
Greene believes that once EHRs have been in place for a while, there will be an emphasis on improving their usability. “Our medical students have extraordinary expectations,” he said. “They want an app to use and if it’s no good, they want another app to try. That’s the bar we have now. The systems still are very hard to use. The vendor community is exhausted with trying to keep up with some of the requirements that they have,” he said. “But we really need to focus on this, because it has become a distraction from good care, and better is certainly possible.”
For our customers, the time is now for a better clinical experience and user interface, which is why they are working with QPID. QPID sits on top of virtually any EHR and delivers relevant patient intelligence directly into clinical workflows. This saves clinicians from scrolling through pages of notes or searching with inadequate tools for data that is inconsistently stored.
We look forward to hearing from you if you are ready to address what Greene calls “a distraction from good care” engendered by systems that are not designed to support care delivery.
Contact us to learn how QPID solves the problem of usability.
I’m delighted to let you know that QPID Health has closed its Series B round of funding. The $12.3m round was led by New Leaf Venture Partners and joined by all investors who participated in the Series A round. Proceeds will be used to accelerate the growth of our team and meet the demand from hospitals and practices to get clinical intelligence from the growing mass of digital patient data locked in EHRs. By “clinical intelligence” we mean the aspects of the patient’s history and status – including diagnoses, procedures, test results and potential safety concerns – that clinicians need to make the best decisions in the clinical trench, while avoiding the wasteful use of resources the comes from lack of access to information.
We are excited about the future of the company and look forward to the contribution of Philippe Chambon and his team at New Leaf, as well as the continued support of our initial investors. We are especially grateful to our customers who are true partners in innovation with QPID.
All of us members of the QPID team feel lucky to be able to contribute to improving healthcare in the U.S., and our funding gives us the means to accelerate our work.